JULIO EDUARDO
NUÑEZ VILLOTA
TITULAR DE UNIVERSIDAD
Universitat Jaume I
Castelló de la Plana, EspañaPublicaciones en colaboración con investigadores/as de Universitat Jaume I (38)
2024
-
Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity
Obesity Research and Clinical Practice, Vol. 18, Núm. 3, pp. 226-231
-
Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: Training-HR study protocol
Current Problems in Cardiology, Vol. 49, Núm. 12
-
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial
Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689
-
In-hospital versus after-discharge complete revascularization in patients with ST segment elevation myocardial infarction and multivessel disease. REVIVA-ST trial
PLoS ONE, Vol. 19, Núm. 5 May
-
Unraveling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID
American Journal of Medicine
-
β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction
JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396
2023
-
Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 511-518
-
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction
Scientific Reports, Vol. 13, Núm. 1
-
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792
-
Long-term recurrent events in ST-elevation myocardial infarction and multivessel disease. The impact of different revascularization strategies
Revista Portuguesa de Cardiologia, Vol. 42, Núm. 5, pp. 445-451
-
Maximal functional capacity in subjects with isolated left bundle branch block: A pilot study
Clinical Cardiology, Vol. 46, Núm. 4, pp. 386-389
-
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction
Journal of Cardiac Failure, Vol. 29, Núm. 5, pp. 849-854
2022
-
Beta-blockers and renin–angiotensin–aldosterone system inhibitors in HFpEF. An urgent need for precision medicine
REC: CardioClinics, Vol. 57, Núm. 3, pp. 162-164
-
Effect of a home-based inspiratory muscular training programme on functional capacity in patients with chronic COVID-19 after a hospital discharge: Protocol for a randomised control trial (InsCOVID trial)
BMJ Open Respiratory Research, Vol. 9, Núm. 1
-
Sex Effect in the Decision to Perform Invasive Coronary Angiography in Patients With Chronic Coronary Syndrome After Undergoing Vasodilator Stress MRI
Journal of Magnetic Resonance Imaging, Vol. 56, Núm. 6, pp. 1680-1690
-
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826
2021
-
Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure
European Journal of Internal Medicine, Vol. 92, pp. 94-99
-
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction
Journal of the American College of Cardiology, Vol. 78, Núm. 21, pp. 2042-2056
-
Evaluation of a novel biomarker of type XXVIII collagen formation, PRO-C28, in samples from cancer and heart failure with preserved ejection fraction patients
Journal of Pharmaceutical and Biomedical Analysis, Vol. 204
-
Iron deficiency and short-term adverse events in patients with decompensated heart failure
Clinical Research in Cardiology, Vol. 110, Núm. 8, pp. 1292-1298